Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy
LEUKEMIA（2016）
摘要
Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy
更多查看译文
关键词
LEU,oncology,haematology,immunology,leukemia,stem cells,oncogenes,growth factors,apoptosis,therapy,fusion genes,lymphoma,hemopoiesis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要